The Global Iohexol Powder Market was valued at USD 575 Million in 2025 and is projected to reach USD 942 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period. This growth is being driven by the rising global volume of diagnostic imaging procedures, particularly CT scans, expanding healthcare infrastructure in emerging economies, and increasing demand for high-purity contrast agents in modern medical diagnostics.

As the healthcare industry continues to advance with more sophisticated imaging technologies and a growing emphasis on accurate, safe diagnostics, the spotlight is on the key suppliers who are driving innovation, quality, and reliable supply of this essential pharmaceutical ingredient. In this blog, we profile the Top 10 Companies in the Iohexol Powder Market—a mix of global pharmaceutical giants, specialized chemical manufacturers, and regional API leaders shaping the future of contrast media production.

---

🔟 1. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Iohexol Powder (API for Omnipaque), High-Purity Pharmaceutical Grade

GE Healthcare is a global leader in medical imaging and contrast media, with its iohexol-based Omnipaque being one of the most widely used non-ionic contrast agents worldwide. The company maintains stringent quality controls for its iohexol powder used in formulating injectable solutions for CT scans, angiography, and other procedures.

Key Initiatives:

• Continuous investment in high-purity API manufacturing

• Global supply chain optimization for diagnostic agents

• Focus on patient safety and reduced side-effect formulations

Download FREE Sample Report: Iohexol Powder Market – View in Detailed Research Report

---

9️⃣ 2. Bracco Imaging S.p.A.

Headquarters: Milan, Italy
Key Offering: Iohexol API and Contrast Media Solutions

Bracco Imaging is a prominent player in diagnostic imaging, offering high-quality iohexol powder as a critical raw material for contrast agents. The company serves major healthcare providers across Europe, North America, and Asia with reliable supply and technical expertise.

Key Initiatives:

• Advanced R&D in contrast agent formulations

• Strategic partnerships with imaging centers worldwide

---

8️⃣ 3. Guerbet Group

Headquarters: Villepinte, France
Key Offering: Iohexol Powder, Pharmaceutical Grade Contrast Agents

Guerbet specializes in medical imaging contrast products and maintains a strong position in the iohexol supply chain. The company focuses on innovation and quality assurance to meet stringent international pharmacopeial standards.

Key Initiatives:

• Expansion of production capacities for iodinated contrast APIs

• Commitment to sustainable manufacturing practices

---

7️⃣ 4. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Iohexol and Related Iodinated Contrast Raw Materials

Bayer is a major force in the contrast media sector, leveraging its extensive chemical expertise to supply high-purity iohexol powder for diagnostic applications. The company supports both established and emerging markets with consistent product quality.

Key Initiatives:

• Focus on next-generation imaging solutions

• Global regulatory compliance and quality systems

Download FREE Sample Report: Iohexol Powder Market – View in Detailed Research Report

---

6️⃣ 5. Otsuka Chemical Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High-Purity Iohexol Powder

Otsuka Chemical brings strong pharmaceutical manufacturing capabilities to the iohexol market, supplying premium-grade powder to formulators worldwide. The company emphasizes precision chemistry and reliability.

Key Initiatives:

• Advanced synthesis technologies

• Partnerships with global pharmaceutical companies

---

5️⃣ 6. Zhejiang Starry Pharmaceutical Co., Ltd.

Headquarters: Xianju, Zhejiang, China
Key Offering: Iohexol API (Pharmaceutical Grade)

Starry Pharmaceutical is a leading Chinese producer of iohexol powder, known for its large-scale manufacturing and competitive supply capabilities. It serves both domestic and international contrast media manufacturers.

Key Initiatives:

• Capacity expansion to meet growing global demand

• Adherence to international GMP standards

---

4️⃣ 7. Haichang Pharmaceutical

Headquarters: China
Key Offering: Iohexol Powder for Contrast Media Production

Haichang Pharmaceutical has established itself as a reliable supplier of iohexol powder, focusing on quality and timely delivery to support the expanding needs of the Asian and global healthcare markets.

Key Initiatives:

• Investment in purification technologies

• Regional supply chain strengthening

---

3️⃣ 8. Grupo Juste (Justesa Imagen)

Headquarters: Spain
Key Offering: Iohexol API and Intermediates

Justesa Imagen, part of Grupo Juste, specializes in iodinated contrast agents and provides high-quality iohexol powder to European and international clients, with a strong emphasis on regulatory compliance.

Key Initiatives:

• European manufacturing excellence

• Focus on sustainable chemical processes

Download FREE Sample Report: Iohexol Powder Market – View in Detailed Research Report

---

2️⃣ 9. Jiangsu Hengrui Pharmaceuticals

Headquarters: Lianyungang, China
Key Offering: Iohexol Powder (API)

Hengrui is a major Chinese pharmaceutical company with growing capabilities in contrast agent raw materials, supplying iohexol powder for both domestic use and export markets.

Key Initiatives:

• Vertical integration in pharmaceutical manufacturing

• Expansion into global API markets

---

1️⃣ 10. Divis Laboratories

Headquarters: Hyderabad, India
Key Offering: Iohexol API and Custom Synthesis

Divis Laboratories is recognized for its expertise in complex API manufacturing, including iohexol powder, supporting global demand with high-quality, cost-effective production.

Key Initiatives:

• Advanced R&D and custom manufacturing services

• Strong regulatory track record with major agencies

Read Full Report: Iohexol Powder Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Iohexol Powder Is Reliable and Innovative

The iohexol powder market is experiencing steady expansion driven by the essential role of contrast-enhanced imaging in modern medicine. While pharmaceutical-grade material dominates, the industry continues to invest in higher purity standards, improved production efficiency, and resilient global supply networks.

📈 Key Trends Shaping the Market:

• Increasing demand for high-purity APIs in emerging healthcare markets

• Regulatory focus on safety and quality of contrast agents

• Technological advancements in imaging requiring consistent raw material supply

• Strategic collaborations between API suppliers and formulation companies

Read Full Report: Iohexol Powder Market – View in Detailed Research Report

The companies listed above are not only supplying a critical raw material—they are enabling the accurate and safe diagnosis that powers healthcare worldwide.